Karadag, Fatma KeklikYenerel, Mustafa NuriMehmet, YilmazTeke, Hava UskudarÖzkocaman, VildanTuglular, TulinErdem, FuatUnal, AliAyyildiz, OrhanOzet, GulsumOzkan, MeldaKaya, EminAyer, MesutSalim, OzanGuvenc, BirolOzdogu, HakanMehtap, OzgurSonmez, MehmetGuler, NilHacioglu, Sibel KabukcuAydogdu, IsmetBektas, OzlenToprak, Selami KocakKaynar, LaleYagci, MunciAksu, SalihTombak, AnilKarakus, VolkanYavasoglu, IrfanOnec, BirgulOzcan, Mehmet AliUndar, LeventAli, RidvanUstun, CelalettinIlhan, OsmanSaydam, GuraySahin, Fahri2024-10-072024-10-072019-11-130006-4971https://doi.org/10.1182/blood-2019-128743https://ashpublications.org/blood/article/134/Supplement_1/4805/428740/Evaluation-of-Patients-with-PNH-Treated-Byhttps://hdl.handle.net/11452/45922Bu çalışma, 07-10, Aralık 2019 tarihlerinde Orlando[Amerika]’da düzenlenen 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/openAccessHematologyMeeting Abstract000577164604216134Supplement 110.1182/blood-2019-128743